GenSight Biologics S.A. (EPA:SIGHT)
France · Delayed Price · Currency is EUR 0.0840
-0.0024 (-2.78%)
Jun 3, 2026, 5:35 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €20.26 million as of June 3, 2026. Its market cap has decreased by -18.03% in one year.
Market Cap
20.26M
Enterprise Value
30.71M
Revenue
652.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.08
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 20.26M, a decrease of -91.97%. That is a compound annual growth rate of -22.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 20.26M | -11.99% |
| Dec 31, 2025 | 23.02M | -30.35% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MaaT Pharma | 55.87M |
| THX Pharma Société Anonyme | 48.98M |
| Fermentalg | 43.96M |
| Nicox | 33.67M |
| genOway Société anonyme | 22.04M |
| Advicenne | 18.13M |
| Aelis Farma | 16.72M |
| NFL Biosciences | 13.00M |